Trade Summary

4 days ago, Gloria Melanie, serving as Chief Operating Officer at Immunovant, Inc. (IMVT), sold 2,036 shares at $39.55 per share, for a total transaction value of $80,531.84. Following this transaction, Gloria Melanie now holds 222,357 shares of IMVT.

This sale represents a 0.91% decrease in Gloria Melanie's stake in the company.

The trade was executed on Wednesday, July 8, 2026 and publicly disclosed via SEC Form 4 filing on Friday, July 10, 2026 at 4:15 PM ET, 2 days after the trade was made.

Immunovant, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.